BioCardia, Inc. Financial Ratios
BCDA|FY2017 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2017 SEC 10-K data.
Key Data Points
- Altman Z-Score -4.83 (distress zone, below 1.23 threshold)
- Piotroski F-Score: 2/9 criteria passed
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2017)
Return on Equity
-110.6%
Profit Margin
-2569.5%
Net Income / Revenue
Asset Turnover
0.04
Revenue / Total Assets
Equity Multiplier
1.22
Total Assets / Equity
Composite: -110.6% (reported: -110.6%)
Profitability
Liquidity
Current Ratio
5.71
Quick Ratio
5.63
Solvency
Interest Coverage
-
Efficiency
Asset Turnover
0.04
Inventory Turnover
3.61
Days Sales Outstanding
72 days
As of FY2017 · SEC Form 10-K · Last checked Jun 21, 2026
Earnings Quality
Accrual Ratio
-20.4%
+1.3pp YoY
Earnings are primarily supported by operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.